Schedule 13D ownership disclosure
OncBioMune Pharmaceuticals, Inc
Security class unavailable · CUSIP: 68235A101
Event date: 2015-09-02
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 31.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-16-007174
- Form type
- SC 13D
- Filer
- HEAD JONATHAN FREDERICK
- CIK
- CIK 1653951
- Filed
- Feb 04, 2016
- Reporting period
- Sep 02, 2015
- Description
- Schedule 13D beneficial ownership